Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs - ScienceDirect
arXiv:1711.04828v1 [q-bio.GN] 13 Nov 2017
Cell Cycle I Molecular Cell Biology November 6, 2014 Stephen Oh, M.D., Ph.D. Assistant Professor Division of Hematology. - ppt download
Cancer Hallmark Automata (I): Model, Therapy and Complexity
Metabolic oncology - Metaboog
Elucidating high-dimensional cancer hallmark annotation via enriched ontology - ScienceDirect
Immune checkpoints | cytokines
https://www.sciencedirect.com/science/article/pii/S2052297517301075 | Download Scientific Diagram
Vascular co-option - ScienceDirect
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs - ScienceDirect
Elucidating high-dimensional cancer hallmark annotation via enriched ontology - ScienceDirect
The molecular and cellular origin of human prostate cancer - ScienceDirect
The molecular and cellular origin of human prostate cancer - ScienceDirect
Primary lung cancer samples cultured under microenvironment-mimetic conditions enrich for mesenchymal stem-like cells that promote metastasis | Scientific Reports
The molecular and cellular origin of human prostate cancer - ScienceDirect
Quante fasi ha un tumore?????
VARIANCE-REDUCED SIMULATION OF MULTISCALE TUMOR GROWTH MODELING∗ 1. Introduction. Tumor growth is a complex biological phenome
The molecular and cellular origin of human prostate cancer - ScienceDirect
Metabolic oncology - Metaboog
Advancing Systems Epidemiology in Cancer - 11. The Immuno-Carcinogen Theory of Cancer
Vascular co-option - ScienceDirect
PDF) Cancer Metastasis and the Immune System Response: CM-IS Modeling by Ising Model
https://www.sciencedirect.com/science/article/pii/S0003999317312509 | Download Scientific Diagram
arXiv:1711.04828v1 [q-bio.GN] 13 Nov 2017
The molecular and cellular origin of human prostate cancer - ScienceDirect
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs - ScienceDirect
